Related Pages for ZYDUSLIFE

Option Chain
Max Pain
Put Call Ratio
Option Analytics
Call OI vs Put OI
Call OI Chg vs Put OI Chg
Call Vol vs Put Vol
Vega Divergence
Buildup & Unwinding
Strike Flow
Future Chain
Future Intraday Analysis
Technical
Financials
Chart
About

Search Symbol
ZYDUSLIFE
Zydus Lifesciences Ltd

939.25 +8.60 (0.92%)

L: 925.1 H: 944.15
Option
- Option
- Option Chain
- Max Pain
- Put Call Ratio
- Option Analytics
Option Analysis
- Option Analysis
- Call OI vs Put OI
- Call OI Chg vs Put OI Chg
- Call Vol vs Put Vol
- Vega Divergence
- Buildup & Unwinding
- Strike Flow
Futures
- Futures
- Future Chain
- Future Intraday Analysis
Company
- Company
- Technical
- Corporate Events & News
- Financials
- Chart
- About

🎨 Holi Special Offer! Get +30 Free Days on Yearly or +10 Free Days on Quarterly — Ends 8th Mar Midnight. View Plans → 🎨 Holi Offer — Ends 8th Mar - View Plans →

NiftyInvest

Market
Max Pain
Put Call Ratio
Option

Option Chain

Straddle Option Chain

Max Pain

Max Pain Table

Put Call Ratio

Put Call Ratio Table

Option Analytics

Option Screener

Call OI vs Put OI

StrikeFlow: Call vs Put Positioning

Call OI Change vs Put OI Change

Call Vol vs Put Vol

Buildup & Unwinding

Vega Divergence

Strategy Builder

Strategy Simulator

Multi Strike OI New

Price vs OI New

Time Series New

Volatility Skew New

Near ATM OI New
Future
Company
Live News
Pricing
My View
Login
Sign-up

[--[65.84.65.76]--]

ZYDUSLIFE

Zydus Lifesciences Ltd

939.25 +8.60 (0.92%)

L: 925.1 H: 944.15

0 results

No results found.

ZYDUSLIFE 939.25

8.6 (0.92%)

Search symbol e.g. NIFTY, RELIANCE, CRUDEOIL

Corporate Actions
Related News

Loading corporate actions

Related News - ZYDUSLIFE

Zydus Lifesciences: Board Meeting Planned To Discuss Share Buyback Proposal On May 19, 2026.

13 May 2026 04:00 PM

Zydus Lifesciences: Board Meeting Planned To Discuss Share Buyback Proposal On May 19, 2026.

Zydus Lifesciences: Enters Agreement With Lupin To Co-Market Semaglutide Injection In India, Zydus Will Promote It As Semaglyntm, Mashematm, And Altermetm, While Lupin Will Sell It As Semanext And Livarise.

17 Mar 2026 12:01 PM

Empowering traders with comprehensive investment insights and advanced market analysis tools. Real-time data, intelligent analytics, and cutting-edge trading intelligence for the Indian stock markets.